Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMEA |
---|---|---|
09:32 ET | 34333 | 9.97 |
09:34 ET | 10296 | 9.7 |
09:36 ET | 3568 | 9.72 |
09:38 ET | 5115 | 9.86 |
09:39 ET | 4976 | 9.85 |
09:41 ET | 3607 | 9.79 |
09:43 ET | 11782 | 9.69 |
09:45 ET | 5557 | 9.694 |
09:48 ET | 3992 | 9.65 |
09:50 ET | 1603 | 9.765 |
09:52 ET | 2448 | 9.72 |
09:54 ET | 1481 | 9.72 |
09:56 ET | 400 | 9.72 |
09:57 ET | 400 | 9.71 |
09:59 ET | 1877 | 9.73 |
10:03 ET | 7321 | 9.76 |
10:06 ET | 1272 | 9.76 |
10:10 ET | 2306 | 9.77 |
10:12 ET | 2091 | 9.74 |
10:14 ET | 3663 | 9.76 |
10:15 ET | 2300 | 9.75 |
10:17 ET | 100 | 9.7586 |
10:19 ET | 5922 | 9.82 |
10:21 ET | 2527 | 9.83 |
10:24 ET | 2835 | 9.8 |
10:26 ET | 1063 | 9.87 |
10:28 ET | 1510 | 9.91 |
10:30 ET | 9923 | 10 |
10:32 ET | 8372 | 9.97 |
10:33 ET | 300 | 9.9975 |
10:35 ET | 1339 | 9.97 |
10:39 ET | 1705 | 9.92 |
10:42 ET | 100 | 9.96 |
10:44 ET | 100 | 9.98 |
10:46 ET | 2430 | 9.9998 |
10:48 ET | 700 | 9.98 |
10:50 ET | 1850 | 9.95 |
10:51 ET | 700 | 9.98 |
10:55 ET | 953 | 9.97 |
10:57 ET | 600 | 9.95 |
11:00 ET | 1120 | 9.9201 |
11:02 ET | 1548 | 9.95 |
11:04 ET | 1100 | 9.97 |
11:06 ET | 1999 | 10 |
11:08 ET | 3154 | 10.03 |
11:09 ET | 1635 | 10.03 |
11:11 ET | 11883 | 9.98 |
11:13 ET | 3099 | 9.99 |
11:15 ET | 204 | 9.97 |
11:18 ET | 100 | 9.99 |
11:20 ET | 2700 | 9.9923 |
11:22 ET | 1422 | 9.98 |
11:24 ET | 1215 | 9.98 |
11:26 ET | 7771 | 10 |
11:27 ET | 1299 | 10.01 |
11:29 ET | 1800 | 10.025 |
11:31 ET | 200 | 9.995 |
11:33 ET | 1282 | 9.95 |
11:36 ET | 5810 | 9.925 |
11:38 ET | 258 | 9.925 |
11:40 ET | 309 | 9.93 |
11:42 ET | 1842 | 9.95 |
11:44 ET | 550 | 9.91 |
11:45 ET | 300 | 9.97 |
11:47 ET | 100 | 9.95 |
11:49 ET | 4834 | 10.08 |
11:51 ET | 1694 | 10.09 |
11:54 ET | 1269 | 10.025 |
11:56 ET | 100 | 10 |
11:58 ET | 550 | 9.9801 |
12:00 ET | 1529 | 10.01 |
12:02 ET | 1150 | 9.98 |
12:03 ET | 1923 | 9.935 |
12:07 ET | 800 | 9.9 |
12:09 ET | 200 | 9.93 |
12:12 ET | 923 | 9.9396 |
12:16 ET | 400 | 9.94 |
12:18 ET | 400 | 9.93 |
12:20 ET | 680 | 9.8931 |
12:21 ET | 1450 | 9.865 |
12:23 ET | 3100 | 9.91 |
12:27 ET | 1400 | 10 |
12:30 ET | 2259 | 9.98 |
12:32 ET | 1174 | 10 |
12:34 ET | 688 | 10.0175 |
12:36 ET | 1338 | 10.001504 |
12:38 ET | 3236 | 9.98 |
12:39 ET | 595 | 9.99 |
12:41 ET | 2437 | 10 |
12:43 ET | 579 | 9.98 |
12:48 ET | 400 | 9.97 |
12:52 ET | 200 | 9.95 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomea Fusion Inc | 344.0M | -2.6x | --- |
Eliem Therapeutics Inc | 346.0M | -2.4x | --- |
Nautilus Biotechnology Inc | 338.6M | -4.9x | --- |
GH Research PLC | 333.5M | 0.0x | --- |
Lyell Immunopharma Inc | 327.7M | -1.4x | --- |
Monte Rosa Therapeutics Inc | 325.3M | -2.4x | --- |
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $344.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 36.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.43 |
EPS | $-3.90 |
Book Value | $4.72 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.